Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,088.85
(
-0.29%
)
US TECH 100
25,845.20
(
-0.10%
)
Dow Jones
49,360.34
(
-0.18%
)
Brent Oil
94.58
(
4.31%
)
Bitcoin
76,037.97
(
0.19%
)
News Focus
News Focus
Post# of 257432
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Friday, 08/07/2020 10:47:38 AM

Friday, August 07, 2020 10:47:38 AM

Post# of 257432
CMPI IPOs 5.75M* shares @$15.00:

https://www.globenewswire.com/news-release/2020/08/07/2074801/0/en/Checkmate-Pharmaceuticals-Announces-Pricing-of-Initial-Public-Offering.html

Checkmate Pharmaceuticals is a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer. Checkmate’s product candidate, CMP-001, is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body’s innate immune system to attack tumors in combination with other therapies.

The stock is -7% as I’m typing.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today